Trial · NCT03427892
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Montgomery-Asberg Depression Rating Scale (MADRS) | Brexpiprazole | MADRS Baseline | 31.95 | Standard Deviation 10.33 | score on a scale |
| The Montgomery-Asberg Depression Rating Scale (MADRS) | Brexpiprazole | MADRS Week 4 | 9.95 | Standard Deviation 8.28 | score on a scale |
| The Montgomery-Asberg Depression Rating Scale (MADRS) | Brexpiprazole | MADRS Week 8 | 10.95 | Standard Deviation 9.59 | score on a scale |
| Young Mania Rating Scale (YMRS) | Brexpiprazole | YMRS Baseline | 4.63 | Standard Deviation 3.22 | score on a scale |
| Young Mania Rating Scale (YMRS) | Brexpiprazole | YMRS Week 4 | 4.21 | Standard Deviation 3.97 | score on a scale |
| Young Mania Rating Scale (YMRS) | Brexpiprazole | YMRS Week 8 | 4.42 | Standard Deviation 5.36 | score on a scale |
| Rey Auditoy Verbal Learning Test | Brexpiprazole | RAVLT T Score Baseline | 37.47 | Standard Deviation 16.67 | T-scores |
| Rey Auditoy Verbal Learning Test | Brexpiprazole | RAVLT T Score Week 4 | 37.79 | Standard Deviation 10.36 | T-scores |
| Rey Auditoy Verbal Learning Test | Brexpiprazole | RAVLT T Score Week 8 | 40.42 | Standard Deviation 11.97 | T-scores |
| Rey Auditoy Verbal Learning Test | Brexpiprazole | RAVLT Delay Baseline | 39.74 | Standard Deviation 13.23 | T-scores |
| Rey Auditoy Verbal Learning Test | Brexpiprazole | RAVLT Delay Week 4 | 37.00 | Standard Deviation 9.010 | T-scores |
| Rey Auditoy Verbal Learning Test | Brexpiprazole | RAVLT Delay Week 8 | 39.26 | Standard Deviation 13.14 | T-scores |
| Stroop Task | Brexpiprazole | STROOP-CW Baseline | 48.11 | Standard Deviation 7.39 | T-scores |
| Stroop Task | Brexpiprazole | STROOP-CW Week 4 | 41.21 | Standard Deviation 34.73 | T-scores |
| Stroop Task | Brexpiprazole | STROOP-CW Week 8 | 50.74 | Standard Deviation 6.82 | T-scores |
| Stroop Task | Brexpiprazole | STROOP-Inter Baseline | 49.89 | Standard Deviation 5.64 | T-scores |
| Stroop Task | Brexpiprazole | STROOP-Inter Week 4 | 43.47 | Standard Deviation 34.95 | T-scores |
| Stroop Task | Brexpiprazole | STROOP-Inter Week 8 | 51.79 | Standard Deviation 5.06 | T-scores |
| Trail Making Test (TMT) | Brexpiprazole | TMT A Score Baseline | 47.74 | Standard Deviation 9.34 | T-scores |
| Trail Making Test (TMT) | Brexpiprazole | TMT A Score Week 4 | 51.16 | Standard Deviation 11.49 | T-scores |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03427892/results